Renaissance Capital logo

Accuray

, Nasdaq: ARAY

Offers an FDA-approved robotic radiosurgery system to treat solid tumors.

Industry: Health Care

First Day Return: +58.2%

Offers an FDA-approved robotic radiosurgery system to treat solid tumors.
IPO Data
IPO Date 02/07/2007
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $288
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Sunnyvale, CA, United States
Founded 1992
Employees at IPO 458
Website www.accuray.com

Accuray (ARAY) Performance